Literature DB >> 19239178

Production of reactive oxygen and nitrogen species in phagocytes is regulated by taurine chloramine.

Chaekyun Kim1, Young-Nam Cha.   

Abstract

Taurine is abundantly present in phagocytic cells and provides protection against cytotoxicity caused by reactive oxygen species (ROS). The reaction between taurine and HOCl, a toxic product of the myeloperoxidase (MPO) system, generates a more stable and less toxic product, taurine chloramine (TauCl). TauCl has also been shown to inhibit the production of superoxide anion (O2-) and nitric oxide (NO). In this review, we compare the effect of taurine and TauCl on the production of these reactive species in phagocytes. First, TauCl inhibit PMA-derived O2- production and this is associated with inhibition of p47phox phosphorylation and of p47phox and p67phox translocation. Second, TauCl inhibits LPS-induced iNOS expression and NO production. This occurs by direct inhibition of Ras activation, ERK1/2 phosphorylation and NF-kappaB activation. Third, TauCl by itself increases the expression of heme oxygenase-1 (HO-1) and enhances HO activity. Carbon monoxide (CO), a product of HO activity, is able to inhibit both O2- and NO production. Combined, these effects of TauCl appear to provide cytoprotection against the inadvertent cytotoxicity caused by overproduction of O2- and NO.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19239178     DOI: 10.1007/978-0-387-75681-3_48

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  17 in total

Review 1.  Taurine and inflammatory diseases.

Authors:  Janusz Marcinkiewicz; Ewa Kontny
Journal:  Amino Acids       Date:  2012-07-19       Impact factor: 3.520

2.  Effects of glutamine, taurine and their association on inflammatory pathway markers in macrophages.

Authors:  Talita Sartori; Guilherme Galvão Dos Santos; Amanda Nogueira-Pedro; Edson Makiyama; Marcelo Macedo Rogero; Primavera Borelli; Ricardo Ambrósio Fock
Journal:  Inflammopharmacology       Date:  2017-10-20       Impact factor: 4.473

3.  NMR-Based Metabolomics Identify Metabolic Change in Spleen of Idiopathic Thrombocytopenic Purpura Patients.

Authors:  Shi Wen; Zhenzhao Wang; Jianghua Feng; Yuanyuan Yang; Xianchao Lin; Heguang Huang
Journal:  Metabolites       Date:  2022-06-19

4.  Taurine ameliorated thyroid function in rats co-administered with chlorpyrifos and lead.

Authors:  Motunrayo Ganiyat Akande; Muftau Shittu; Chidiebere Uchendu; Lukuman Surakat Yaqub
Journal:  Vet Res Commun       Date:  2016-08-25       Impact factor: 2.459

5.  Protection effect of taurine on nitrosative stress in the mice brain with chronic exposure to arsenic.

Authors:  Ning Ma; Mikio Sasoh; Shosuke Kawanishi; Hiromichi Sugiura; Fengyuan Piao
Journal:  J Biomed Sci       Date:  2010-08-24       Impact factor: 8.410

Review 6.  Taurine and the renal system.

Authors:  Russell W Chesney; Xiaobin Han; Andrea B Patters
Journal:  J Biomed Sci       Date:  2010-08-24       Impact factor: 8.410

Review 7.  Perinatal taurine exposure affects adult arterial pressure control.

Authors:  Sanya Roysommuti; J Michael Wyss
Journal:  Amino Acids       Date:  2012-10-16       Impact factor: 3.520

8.  Effect of taurine on intestinal recovery following intestinal ischemia-reperfusion injury in a rat.

Authors:  I Sukhotnik; I Aranovich; Y Ben Shahar; N Bitterman; Y Pollak; D Berkowitz; D Chepurov; A G Coran; A Bitterman
Journal:  Pediatr Surg Int       Date:  2015-10-26       Impact factor: 1.827

9.  White blood cell differentials enrich whole blood expression data in the context of acute cardiac allograft rejection.

Authors:  Casey P Shannon; Zsuzsanna Hollander; Janet Wilson-McManus; Robert Balshaw; Raymond T Ng; Robert McMaster; Bruce M McManus; Paul A Keown; Scott J Tebbutt
Journal:  Bioinform Biol Insights       Date:  2012-04-10

10.  Evaluation of glycine-bearing celecoxib derivatives as a colon-specific mutual prodrug acting on nuclear factor-κB, an anti-inflammatory target.

Authors:  Sunyoung Lee; Yonghyun Lee; Wooseong Kim; Joon Nam; Seongkeun Jeong; Jin-Wook Yoo; Min-Soo Kim; Hyung Ryong Moon; Yunjin Jung
Journal:  Drug Des Devel Ther       Date:  2015-08-07       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.